Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 34 for:    denosumab AND breast cancer

Biomarker Study of the Antitumoral Activity of Denosumab in the Pre- Operative Setting of Early Breast Cancer (D-BIOMARK)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03691311
Recruitment Status : Recruiting
First Posted : October 1, 2018
Last Update Posted : August 7, 2019
Sponsor:
Collaborator:
Amgen
Information provided by (Responsible Party):
Institut Català d'Oncologia

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 5, 2020
Estimated Study Completion Date : February 5, 2021